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West Nile virus (WNV) epizootiology was monitored
from 2002 through 2005 in the area surrounding Grand
Forks, North Dakota. Mosquitoes were tested for infection,
and birds were surveyed for antibodies. In 2003, WNV was
epidemic; in 2004, cool temperatures precluded WNV
amplification; and in 2005, immunity in passerines
decreased, but did not preclude, WNV amplification.
W
est Nile virus (WNV) is a flavivirus with an enzoot-
ic cycle that involves primarily mosquitoes and
birds in the order Passeriformes. Since its introduction into
the northern prairies of the United States in 2002, WNV
has flourished. In 2003 and 2005, the prairie states of
North Dakota, South Dakota, and Nebraska recorded the
highest incidence of cases in humans (per 100,000 county
residents) for the entire United States (1). Although WNV
is still new to the region, the ecology of the northern prairie
seems to offer favorable conditions for its continued
enzootic transmission. This report chronicles the initial
establishment of WNV within the central Red River Valley
of eastern North Dakota and northwestern Minnesota
(Figure).
The Study
Host-seeking mosquitoes were collected in and around
Grand Forks, North Dakota, by using Mosquito Magnet
traps (American Biophysics Corp., North Kingston, RI,
USA) for 4 transmission seasons, from early summer 2002
through fall 2005. Mosquitoes were sorted by species and
tested for WNV by using reverse transcriptase PCR assays.
WNV was detected only in Culex tarsalis (2).
Passerine birds in and around Grand Forks were sur-
veyed for antibodies to WNV for 3 transmission seasons:
June 24–October 27, 2003, April 4–July 7, 2004, and May
17–August 11, 2005. In 2003 and early 2004, birds were
captured by using mist nets, blood (<0.1 mL) was
obtained by brachial venipuncture, and birds were
released. Later in 2004 and in 2005, necropsies were per-
formed on dead birds. Blood spots were placed on filter
paper and later eluted in 250 µLsaline. Samples were test-
ed for anti-WNV antibodies by using a qualitative epi-
tope-blocking ELISA (3).
This is the first report of seroprevalence of WNV in
passerines in the northern prairies. A total of 277 birds (11
species) were tested (Table 1). In 2003, seroprevalence
was relatively low (17%). The first seropositive bird was
captured July 24, 2003, 4 days after the first WNV-positive
pool of Cx. tarsalis was detected (2). Most seropositive
birds (11 of 14) were collected in September, when migra-
tory species were leaving and vector populations were
waning. Thus, a lag occurred between peak abundance of
infected vectors in mid- to late August 2003 (2) and sero-
conversion of passerines. Seroprevalence rates were sig-
nificantly higher in 2004 and 2005 than in 2003 (Table 1,
Fisher exact tests, p<0.0001) and were higher than most
seroprevalences reported for passerines in the eastern and
southeastern regions of the United States (4–6). All passer-
ine species sampled in 2004 and 2005 contained seroposi-
tive birds, which indicated that all these species were
preyed on by vectors regardless of differences in their nest-
ing habitats (e.g., cattail marshes, peridomestic). American
robins, common grackles, and red-winged blackbirds
showed increased seroprevalence from 2003 to 2004. High
seroprevalence was maintained in passerines in 2005
despite low WNV activity (i.e., low natural boosting) dur-
ing 2004 (2), which suggests that passerine immunity to
WNV may last longer than a single season (7,8).
Surprisingly, American crows had a high seropreva-
lence to WNV. Previous laboratory and field studies have
indicated that most American crows die so quickly from
WNV infection that they never have time to seroconvert
(9–11). Why crows in the Red River Valley survive WNV
infection is not known. One possibility is that WNV has
undergone genetic changes with a concurrent loss in viru-
lence as it spread westward from forest ecosystems with
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 8, August 2006 1245
*University of North Dakota, Grand Forks, North Dakota, USA
Figure. Red River Valley of North Dakota, Minnesota, and
Manitoba.Cx. pipiens and Cx. restuans as its primary vectors into
prairie ecosystems with Cx. tarsalis as its primary vector
(2,12,13).
Annual data on seroprevalence in passerines, environ-
mental temperatures, reporting of human cases, and mini-
mum infection rates (MIR) in vector populations are
summarized in Table 2.
Conclusions
Environmental conditions from 2002 to 2005 produced
a natural field experiment, which demonstrated the differ-
ing magnitudes by which environmental temperature and
host immunity affected local WNV activity. Despite warm
temperatures and high vector abundance, WNV activity
was low during its introductory year (2002), as indicated
by low numbers of human cases, undetectably low season-
al MIR, and by low seroprevalence in passerines in 2003.
Because WNV had only recently arrived, presumably there
was neither sufficient time nor number of infection nidi to
promote extensive amplification cycles. However, 2003
was an epidemic year for WNV, as indicated by the
increased number of human cases statewide and the high
MIR in the local vector population. The relatively low
level of immunity in passerines at the time also likely con-
tributed to the epidemic. In 2004, unusually cool environ-
mental temperatures prolonged vector larval development,
adult emergence, and the arboviral extrinsic incubation
period. As a result, duration of the 2004 transmission sea-
son was nearly half that of the preceding seasons (Table 2).
Thus, WNV activity during 2004 was low (i.e., reduced
vector abundance, number of human cases, and seasonal
MIR), and the virus had insufficient time to undergo exten-
sive amplification cycles, similar to the situation that
occurred during the introductory year of 2002.
However, the epidemic conditions of 2003 had pro-
duced a high level of herd immunity in the local bird pop-
ulation in 2004. This immunity carried over into 2005.
(Note: most migratory passerine species live for several
years and return each year to the same general locale to
breed.) In 2005, environmental temperature, length of
transmission season, and vector abundance were all nearly
identical to those of the epidemic year of 2003. Yet the
intensity of WNV activity during 2005 was considerably
less than that during 2003. The big difference between
DISPATCHES
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The high prevalence of immunity during 2005 may have
contributed to preventing another epidemic, but it did not
totally eliminate WNV activity. Levels of WNV activity
during 2005 (as measured by human cases and mosquito
MIR) were intermediate between those of the epidemic
year (2003) and both the introductory year (2002) and the
coldest year (2004). Thus, environmental temperature dic-
tated the ultimate success (or more precisely, the failure) of
WNV amplification within the central Red River Valley
during 2004, whereas even high levels of herd immunity
among the reservoir population exerted only a moderating
effect on WNV activity during 2005.
Whether the level of WNV activity observed during
2005 will be representative of the arbovirus’s natural equi-
librium within the central Red River Valley remains to be
seen. One uncertainty is how seasonal transmission is ini-
tiated. Is WNV reintroduced every spring through infected
migratory birds or wind-blown mosquitoes from the
south? Or does WNV survive the harsh winters inside
mosquitoes undergoing diapause, only to reemerge in the
spring? Either or both of these scenarios could be correct,
but one conclusion is certain: the incidence of WNV dis-
ease in horses from North Dakota during June of 2002 and
again in May of 2005 (15) indicates that WNV becomes
active in the northern Great Plains well in advance of the
first summer brood of its primary vector, Cx. tarsalis (2).
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